Artemis Raipur starts at 10% occupancy, targets 12-15-month breakeven

In its initial Q2 FY27 operating period, Artemis Shanti Hospital in Raipur (Artemis Raipur) reported 10% occupancy, Rs 5.3 crore revenue and a Rs 9 crore loss; management is targeting breakeven within 12 to 15 months after clinical operations began on July 29, 2026.

How did Artemis Raipur perform in its initial quarter?

Artemis Raipur reported Rs 5.3 crore of revenue in its initial operating quarter, exceeding management's Rs 4.3 crore expectation by Rs 1 crore. Management placed the Q2 FY27 loss at Rs 9 crore, within its earlier expectation of a Rs 9 crore to Rs 10 crore loss as the hospital established operations.

Occupancy was 10% at the November 2, 2026 earnings call, one day before the formal inauguration management described. Artemis Raipur has 300 beds overall, while management cited a census of 250 operational beds, indicating that the hospital was still in an early utilisation phase despite theatres and a catheterisation laboratory being operational from July 29.

The revenue result alongside 10% occupancy reflected the initial clinical mix, according to management. Artemis Raipur reported average revenue per occupied bed, or ARPOB, of Rs 30,000 to Rs 32,000, above the Rs 26,000 to Rs 27,000 range management cited for competitors and above its own initial assessment.

Why did Artemis Raipur report a Rs 9 crore loss?

Artemis Raipur reported a Rs 9 crore loss because its cost base was largely in place while occupancy was 10% and revenue was Rs 5.3 crore. Management put quarterly operating costs at around Rs 10 crore, including fixed costs, during the first operating period.

Management said most fixed and variable expenses had already been incurred for clinical teams and departments including neurosurgery, neurology, transplants, robotic surgery, cardiology and cardiac surgery. It expects only limited additions, such as a few nurses, rather than a major increase in the cost base as patient volumes rise.

This means the ramp-up thesis depends on revenue rising faster than costs through greater utilisation and more procedures. That is management's expectation, rather than a reported outcome: the call did not provide a full reconciliation between the Rs 5.3 crore revenue, the approximately Rs 10 crore operating cost and the Rs 9 crore loss.

When does Artemis Raipur expect to break even?

Artemis Raipur is targeting breakeven within 12 to 15 months from the early operating phase, according to management. Management also said it would try internally to improve on that timetable, but did not disclose a specific revenue, occupancy or profit threshold required to reach breakeven.

For the coming quarters, management said occupancy should reach at least 20% to 25%, with 30% also mentioned as a possible level. Reaching 20% would double the 10% occupancy reported at the November 2 call, although management did not specify the quarter in which it expects the range to be achieved.

Management said sequential performance should improve because the key cost base is already installed. Doctors were onboarded from July 1, 2026, while theatres and the catheterisation laboratory began operating on July 29, so the initial Q2 FY27 period included clinical staffing costs before the hospital had developed a full patient base.

Can Artemis Raipur increase revenue per occupied bed?

Artemis Raipur began with ARPOB of Rs 30,000 to Rs 32,000, compared with the Rs 26,000 to Rs 27,000 competitor level cited by management. ARPOB measures revenue per occupied bed, making it sensitive to both the procedures performed and the intensity of care delivered.

Management said its internal plan had been to ramp ARPOB to Rs 55,000, and it cited Rs 58,000 as a potential outcome if the initial trajectory continued. The company did not give a timetable for reaching those levels and presented them as an internal expectation rather than formal financial guidance.

Management attributed the initial ARPOB to a top-down clinical launch focused on high-end surgeries rather than routine cases. It said the specialist roster, including doctors recruited from across Chhattisgarh, supported the early treatment mix that produced Rs 30,000 to Rs 32,000 of ARPOB.

What supports Artemis Raipur's occupancy ramp-up plan?

Artemis Raipur is a 300-bed multispecialty tertiary-care hospital intended to serve central India and, in management's description, operate as a nodal hospital for Chhattisgarh. Management cited the hospital's central Raipur location, corporate-hospital format and specialist teams as factors supporting a rise from 10% occupancy.

Management contrasted Artemis Raipur with established local hospitals it said were 40 to 50 years old and had not received infrastructure upgrades. It also said newer branded facilities were being developed in New Raipur, farther from the city centre, although these views were management's assessment rather than independently verified market-share data.

The Raipur ramp-up sits within a wider capacity plan of around 2,000 operational beds over the next three to five years. Artemis Medicare Services Limited also plans to add 250 beds through Tower 4 at its Gurugram campus by H2 FY28, while the proposed South Delhi hospital is expected to commence operations in Q4 FY29-FY30 with more than 650 beds.

Conclusion

Artemis Raipur's first operating-quarter figures show that revenue exceeded management's Rs 4.3 crore expectation, but utilisation remained at 10% against an approximately Rs 10 crore quarterly operating cost base. The hospital's Rs 30,000 to Rs 32,000 ARPOB suggests that the initial focus on complex procedures supported revenue despite low occupancy, while the Rs 9 crore loss reflects the cost of launching a largely staffed clinical platform.

The next disclosed milestones are occupancy progression toward management's 20% to 25% near-term range and the 12-to-15-month breakeven target. Investors can also watch whether ARPOB advances toward the internally planned Rs 55,000 to Rs 58,000 range as Artemis Raipur expands patient volumes and sustains its higher-end procedure mix.